Tyler Wood, PharmD, BCBBS, CRCS, 340B ACE, CHFP

As pharmaceutical markets become increasingly dynamic, health systems may benefit from shifting toward unit-level economic frameworks that evaluate cost and margin performance.

With the introduction of expensive drugs and associated challenges for hospital budgets, pharmacy leaders benefit from strategically managing financial, clinical, and regulatory factors for sustainable care delivery.

Historically there was little distinction, but recent changes bring new challenges.